TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/3/23 06:00 | 12/29/22 | TCON | Tracon Pharmaceuticals, Inc. | Health | BioPrd | Biological Products, (No Diag | Brown Scott B. | CA | O | CFO | P | 5 | 1.49 | 0 | 4 | 19 | 22 | D | |||||||||||||||
9/14/22 16:05 | 9/12/22 | TCON | Tracon Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Brown Scott B. | CA | O | CFO | P | 5 | 2.02 | 0 | 3 | 21 | 15 | D | ||||||||||||||
3/30/22 07:20 | 3/29/22 | TCON | Tracon Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Brown Scott B. | CA | O | CFO | P | 3 | 2.82 | 0 | 1 | 13 | 9 | D | ||||||||||||||
8/17/21 17:01 | 8/13/21 | TCON | Tracon Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Brown Scott B. | CA | O | CFO | P | 4 | 3.69 | 0 | 1 | 15 | 8 | D | ||||||||||||||
3/9/21 06:00 | 3/8/21 | TCON | Tracon Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Brown Scott B. | CA | O | CFO | P | 8 | 8.30 | 0 | 1 | 47 | 3 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |